Wolverine Trading’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,100
Closed -$44.2K 5265
2024
Q4
$44.2K Buy
+10,100
New +$41K ﹤0.01% 5006
2024
Q2
Sell
-23,400
Closed -$204K 4840
2024
Q1
$204K Buy
+23,400
New +$284K ﹤0.01% 3795
2022
Q1
Sell
-12,600
Closed -$147K 5893
2021
Q4
$147K Sell
12,600
-300
-2% -$3.68K ﹤0.01% 4903
2021
Q3
$171K Sell
12,900
-12,300
-49% -$159K ﹤0.01% 5454
2021
Q2
$321K Sell
25,200
-9,400
-27% -$108K ﹤0.01% 4332
2021
Q1
$379K Buy
+34,600
New +$366K ﹤0.01% 4124
2020
Q4
Sell
-14,000
Closed -$132K 5122
2020
Q3
$132K Buy
+14,000
New +$139K ﹤0.01% 4033
2019
Q3
Sell
-11,300
Closed -$124K 4661
2019
Q2
$124K Buy
+11,300
New +$127K ﹤0.01% 3934
2019
Q1
Sell
-38,805
Closed -$322K 4865
2018
Q4
$322K Buy
38,805
+19,462
+101% +$223K ﹤0.01% 3106
2018
Q3
$299K Buy
19,343
+7,403
+62% +$117K ﹤0.01% 3735
2018
Q2
$154K Hold
11,940
﹤0.01% 4549
2018
Q1
$154K Sell
11,940
-1,075
-8% -$13.4K ﹤0.01% 4549
2017
Q4
$163K Sell
13,015
-13,372
-51% -$175K ﹤0.01% 4263
2017
Q3
$349K Buy
+26,387
New +$363K ﹤0.01% 3064
2016
Q4
Sell
-14,686
Closed -$189K 4760
2016
Q3
$189K Buy
+14,686
New +$172K ﹤0.01% 3874

Other funds holding IRWD

Wolverine Trading's IRWD Position: Q1 2025 in Review

Wolverine Trading sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 12,502 shares — an estimated $54.8K sold.

Wolverine Trading first reported a position in IRWD in Q3 2017 and held it in 11 quarters. The position peaked at $330K in Q1 2021. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Wolverine Trading reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 12,502 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $54.8K.
  • Wolverine Trading first reported a position in Ironwood Pharmaceuticals in Q3 2017 and held it in 11 quarters.
  • Wolverine Trading's Ironwood Pharmaceuticals position peaked at $330K in Q1 2021.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.